Showing 821 - 840 results of 1,143 for search '"kidney disease"', query time: 0.06s Refine Results
  1. 821

    Protective Effects of Tormentic Acid on Unilateral Ureteral Obstruction-Induced Renal Injury, Inflammation, and Fibrosis: A Comprehensive Approach to Reducing Oxidative Stress, Apo... by Ah Young Yang, Jung-Yeon Kim, Mi-Gyeong Gwon, Hyun Hee Kwon, Jaechan Leem, Eon-Ju Jeon

    Published 2024-12-01
    “…Chronic kidney disease (CKD) progresses through mechanisms involving inflammation, fibrosis, and oxidative stress, leading to the gradual structural and functional deterioration of the kidneys. …”
    Get full text
    Article
  2. 822

    Validation of the Kidney Failure Risk Equation in the Colombian Population by C. Larrarte, J. Vesga, F. Ardila, A. Aldana, D. Perea, M. Sanabria

    Published 2024-01-01
    “…Introduction. Chronic kidney disease prevention programs must identify patients at risk of early progression to provide better treatment and prolong kidney replacement therapy-free survival. …”
    Get full text
    Article
  3. 823

    Significant Independent Predictors of Vitamin D Deficiency in Inpatients and Outpatients of a Nephrology Unit by Recep Bentli, Hulya Taskapan, Halil Toktaş, Ozkan Ulutas, Adnan Ozkahraman, Melda Comert

    Published 2013-01-01
    “…Aims. Kidney disease was found to be a major risk factor for vitamin D deficiency in a population study of patients hospitalized. …”
    Get full text
    Article
  4. 824

    Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy by Te-Fu Lin, Ping-I Hsu, Kung-Hung Lin, Feng-Woei Tsay, Tzung-Jiun Tsai, Yan-Hua Chen, Hsien-Chung Yu

    Published 2017-01-01
    “…Serial eGFRs were calculated every 3 months using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. …”
    Get full text
    Article
  5. 825

    The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) by Denda Nikola I., Maletin Nemanja Z., Atanasković Marko B., Vučković Biljana A., Rašković Aleksandar L.

    Published 2024-01-01
    “…Methods: A thorough review of literature from 2000 to 2023 via PubMed focused on SGLT2 inhibitors' pharmacology and clinical impact on T2DM, heart failure, and chronic kidney disease. Twenty relevant studies were analyzed to understand differences between these inhibitors, refining their efficacy and safety profiles. …”
    Get full text
    Article
  6. 826

    Development and validation of a clinical prediction model of acute kidney injury in intensive care unit patients at a rural tertiary teaching hospital in South Africa: a study prot... by Olanrewaju Oladimeji, Constance Sewani-Rusike, Busisiwe Mrara, Fathima Paruk

    Published 2022-07-01
    “…With the only therapeutic option being supportive therapy, prevention and early diagnosis will facilitate timely interventions to prevent progression to chronic kidney disease. While many factors have been identified as predictive of AKI, none have shown adequate sensitivity or specificity on their own. …”
    Get full text
    Article
  7. 827

    Glomerular Filtration Result in Patients with Hypertensive Emergencies by Manuel Tasis Hernández, Wendy Talavera Hernández, Valentina Edighill Villanueva, Aliucha María Rodríguez Díaz, Taimy Calvera Castro, Juan Francisco Gastón Del Monte

    Published 2020-06-01
    “…<strong>Foundation</strong>: hypertensive emergencies may be the presentation of an underlying chronic kidney disease; in turn kidney damage may be the cause that leads to hypertensive emergency. …”
    Get full text
    Article
  8. 828

    Characteristics and Clinical Course of Patients with Acute Myocardial Infarction and ST-segment Elevation with and without Interatrial Block by Francisco de Jesús Valladares Carvajal, Verónica Mercedes Carretero Acosta, Raimundo Carmona Puerta, Aymara Marcia Hernández Cardoso, Ernesto Julio Bernal Valladares

    Published 2023-08-01
    “…Demographic variables were analyzed: age, sex, skin color and between clinics: toxic habits; (smoker, ex-smoker); medical history (myocardial infarction, angina, peripheral arterial disease, arterial hypertension, type 2 diabetes mellitus, chronic kidney disease; infarct location (anterior, inferior, left bundle branch block); complications: heart failure, atrial fibrillation, ventricular tachycardia/ventricular fibrillation, atrioventricular conduction disorders, mechanical complication, post infarction angina, arterial embolism) and discharge status (alive or deceased). …”
    Get full text
    Article
  9. 829
  10. 830

    Translational regulation of PKD1 by evolutionarily conserved upstream open reading frames by Lei Chen, Xia Gao, Xiangshen Liu, Ye Zhu, Dong Wang

    Published 2025-12-01
    “…Mutations in PKD1 coding sequence and abnormal PKD1 expression levels contribute to the development of autosomal-dominant polycystic kidney disease, the most common genetic disorder. Regulation of PKD1 expression by factors located in the promoter and 3´ UTR have been extensively studied. …”
    Get full text
    Article
  11. 831

    Engineering and design of a COF-coated probe for the detection and removal of flumequine and enrofloxacin antibiotics in foodstuffs: a molecular dynamics simulation approach by Alireza Nakhaei, Heidar Raissi, Maryam Alaei, Farzaneh Farzad

    Published 2025-02-01
    “…However, their overuse can lead to significant health risks, including water contamination, antibiotic-resistant pathogens, kidney disease, reproductive disorders, cancers, and severe allergic reactions. …”
    Get full text
    Article
  12. 832

    Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders by B. L. Goh, A. Soraya, A. Goh, K. L. Ang

    Published 2018-01-01
    “…Hyperphosphatemia in chronic kidney disease (CKD) patients is often treated with calcium carbonate (CaCO3) despite the fact that CaCO3 is associated with increased calcium load and potentially increased cardiovascular risk. …”
    Get full text
    Article
  13. 833

    Prevalence of Hypercalcaemia in a Renal Transplant Population: A Single Centre Study by Tony Amin, P. Toby Coates, Jeffrey Barbara, Paul Hakendorf, Nazmul Karim

    Published 2016-01-01
    “…Results. 679 renal transplant recipients with a functioning graft were studied and 101 were hypercalcaemic between March 2011 and June 2011 (15%). 60% of the hypercalcaemic patients were male and 40% were female, with chronic glomerulonephritis (39%) being the commonest cause of their end stage kidney disease (ESKD). Prevalence was similar in those that had haemodialysis and peritoneal dialysis pretransplantation. …”
    Get full text
    Article
  14. 834

    Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome by Kostas Archontogeorgis, Evangelia Nena, Christina Tsigalou, Athanasios Voulgaris, Maria Xanthoudaki, Marios Froudarakis, Paschalis Steiropoulos

    Published 2016-01-01
    “…Obstructive sleep apnea syndrome (OSAS) is associated with systemic inflammation and increased risk of cardiovascular and chronic kidney disease. Cystatin C (Cyst C) is a novel biomarker of both latent renal damage and cardiovascular disease. …”
    Get full text
    Article
  15. 835

    Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis by Jerzy Chudek, Marta Pośpiech, Anna Chudek, Michał Holecki, Monika Puzianowska-Kuźnicka

    Published 2025-01-01
    “…In addition, chronic kidney disease, the most significant confounder disturbing the association between vascular damage and circulating OPG levels, decreases the usefulness of OPG as a BM in CAS. …”
    Get full text
    Article
  16. 836

    Urinary electrolyte parameters in sepsis-associated acute kidney injury: A prospective observational study by Rajathadri Hosur Ravikumar, Anjan Trikha, Rashmi Ramachandran, Sudip Kumar Datta, Mrudula Prasanna, Vimi Rewari

    “…Patients were monitored for 7 days to assess for acute kidney injury (AKI) according to Kidney Disease Improving Global Outcomes (KDIGO) definition criteria, mortality rates, and the need for renal replacement therapy. …”
    Get full text
    Article
  17. 837

    Renal Dysfunction, Metabolic Syndrome and Cardiovascular Disease Mortality by David Martins, Chizobam Ani, Deyu Pan, Omolola Ogunyemi, Keith Norris

    Published 2010-01-01
    “…Renal disease is commonly described as a complication of metabolic syndrome (MetS) but some recent studies suggest that Chronic Kidney disease (CKD) may actually antecede MetS. Few studies have explored the predictive utility of co-clustering CKD with MetS for cardiovascular disease (CVD) mortality. …”
    Get full text
    Article
  18. 838

    Uji Kesesuaian Hasil Pemeriksaan Sedimen Urine Metode Shih-Yung pada Volume Urine 10 mL dan 5 mL by Putri Niawaty, Rikarni Rikarni, Dwi Yulia

    Published 2021-09-01
    “…Pediatric patients and kidney disease patients with oliguria difficult to get 10mL urine samples, so it needs to be studied to determine the accuracy of results with smaller sample volumes. …”
    Get full text
    Article
  19. 839

    The Relation of Coffee Consumption to Serum Uric Acid in Japanese Men and Women Aged 49–76 Years by Ngoc Minh Pham, Daigo Yoshida, Makiko Morita, Guang Yin, Kengo Toyomura, Keizo Ohnaka, Ryoichi Takayanagi, Suminori Kono

    Published 2010-01-01
    “…Study subjects were derived from the baseline survey of a cohort study on lifestyle-related diseases, and included 11.662 men and women aged 49–76 years; excluded were those with medication for gout and hyperuricemia, use of diuretic drugs, and medical care for cancer or chronic kidney disease. Statistical adjustment was made for body mass index, alcohol use, hypertension, diabetes mellitus, and other factors. …”
    Get full text
    Article
  20. 840

    Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease by Symeon Savvopoulos, Haralampos Hatzikirou, Herbert F Jelinek

    Published 2024-02-01
    “…Clinically, diabetes and associated comorbidities are identified by biochemical and physical characteristics including glycemia, glycated hemoglobin (HbA1c), and tests for cardiovascular, eye and kidney disease. Objectives: Diabetes may have a common etiology based on inflammation and oxidative stress that may provide additional information about disease progression and treatment options. …”
    Get full text
    Article